The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
these patients can walk around with a bilirubin of 1.6 to two and they seem to be getting a benefit from it and they also seem to have lower LDL and even if they don't have lower LDL because the literature is mixed on this they always have lower ox LDL and it may be that the best x1 is that Billy Rubin has antioxidative properties so they get this protection from cardiovascular disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
it's a u-shaped curve or an inverted u-shaped curve rather meaning as that Billy Rubin gets higher and higher they start to lose any of that benefit right meaning whatever oxidative benefit they get it's more than being outweighed by the damage that comes from that elevated bilirubin